Goldman Sachs’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,000
Closed -$3.92M 6881
2025
Q3
$3.92M Buy
+20,000
New +$3.29M ﹤0.01% 3870
2025
Q2
Sell
-240,000
Closed -$14.3M 6498
2025
Q1
$14.3M Buy
240,000
+215,000
+860% +$19.9M ﹤0.01% 2349
2024
Q4
$3.31M Sell
25,000
-164,700
-87% -$15.5M ﹤0.01% 3852
2024
Q3
$9.94M Sell
189,700
-563,600
-75% -$26.5M ﹤0.01% 2733
2024
Q2
$45.6M Buy
+753,300
New +$52.2M 0.01% 1223

Other funds holding ALAB

Goldman Sachs's ALAB Position: Q1 2026 in Review

Goldman Sachs increased its Astera Labs (ALAB) stake by 5.1% in Q1 2026, buying an estimated $9.57M and bringing the position to 1,380,114 shares worth $151M. The position accounts for 0.02% of the portfolio, ranked #817.

Goldman Sachs first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $218M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Goldman Sachs held 1,380,114 shares of Astera Labs worth $151M as of Q1 2026.
  • Goldman Sachs bought 67,187 Astera Labs shares in Q1 2026, an estimated $9.57M.
  • Astera Labs made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #817 holding.
  • Goldman Sachs first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Goldman Sachs's Astera Labs position peaked at $218M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.